BSE Live
Oct 03, 16:01Prev. Close
9221.25
Open Price
9259.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 03, 15:59Prev. Close
9222.00
Open Price
9248.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
9331.00 (40)
Cash Flow of AstraZeneca Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 156.36 | 219.54 | 134.10 | 83.04 | 127.09 | |
Net CashFlow From Operating Activities | 65.36 | 27.87 | 58.29 | 100.80 | 104.78 | |
Net Cash Used In Investing Activities | 30.80 | 21.74 | 18.11 | 4.74 | 173.03 | |
Net Cash Used From Financing Activities | -65.59 | -44.38 | -24.48 | -9.46 | -8.97 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 30.57 | 5.23 | 51.92 | 96.08 | 268.84 | |
Cash And Cash Equivalents Begin of Year | 505.57 | 500.34 | 448.42 | 352.34 | 83.50 | |
Cash And Cash Equivalents End Of Year | 536.14 | 505.57 | 500.34 | 448.42 | 352.34 |
31.07.2025
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
07.04.2025
10.03.2025
06.06.2025
AstraZeneca Standalone March 2025 Net Sales at Rs 480.48 crore, up 25.39% Y-o-Y
17.02.2025
AstraZeneca Standalone December 2024 Net Sales at Rs 440.29 crore, up 43.98% Y-o-Y
21.11.2024
AstraZeneca Standalone September 2024 Net Sales at Rs 408.00 crore, up 31.16% Y-o-Y
13.08.2024
AstraZeneca Standalone June 2024 Net Sales at Rs 387.52 crore, up 31.16% Y-o-Y